Pharma Mar s.a. preclinical data

Results of preclinical studies with three marine-based compounds, ET-743, KF and THIO, indicate their potential to inhibit several cancers, according to data presented at the annual meeting of the European Conference on Chemotherapy and Oncology in Paris.

ET-743 has shown in vivo curative activity against breast cancer, and significant activity in melanoma, non-small cell lung cancer, and ovarian cancer, the Madrid company said. Phase I trials in the U.S. and Europe are scheduled to begin soon. ...